跳至主要内容
临床试验/NCT04634201
NCT04634201终止不适用

Effect of Probiotics in Addition to Dental Brushing on Gum Inflammation and Oral Microbiota in Patients With Fixed Orthodontic Appliances

University Hospital, Lille2 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2022年3月23日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
3
试验地点
2
主要终点
Variation of gingival index (Löe Silness) between baseline and 6 months

研究概览

简要总结

Gingival inflammation (gingivitis) is commonly reported in teenagers with fixed orthodontic devices (FOD). Indeed, FODs promote the accumulation of plaque and interfere with the efficacy of tooth brushing. According to in vitro and in vivo studies, the administration of oral probiotic bacteria including Lactobacillus reuteri may reduce the number of periodontal pathogens in saliva and dental plaque. A recent systematic review shows a positive effect of probiotics in addition to tooth brushing in the treatment of periodontitis. However, there is insufficient data regarding the effect of probiotics in the prevention of gum diseases. The aim of this double-blind randomized placebo-controlled study is to assess the effect of probiotics, in addition to dental brushing, on gum inflammation and the composition of the oral microbiota in teenagers with fixed orthodontic appliances

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
12 Years 至 16 Years(Child)
性别
All
接受健康志愿者

入选标准

  • adolescents aged 12 to 16 benefiting from social security coverage
  • in good general health in brushing and taking treatments
  • Have FODs
  • who consent to the study and whose parents have given their consent
  • suitable for orthodontic treatment in view of his oral state

排除标准

  • inability to obtain informed consent
  • use of another probiotic or toothpaste / antiseptic mouthwash ≤ 1 month before inclusion
  • allergy or hypersensibiliity to the active substance or to any of the excipients listed in the Gum® PerioBalance® user guide)
  • no history of antibiotic therapy, antiseptic mouthwash ≤ 1 month before inclusion
  • medical contraindication (immunosuppression, pathology requiring prophylactic antibiotic therapy before dental care)
  • physiological, pathological condition, medication or behavior that may have repercussions on the oral cavity (eg: pregnancy, diabetes, antiepileptics, tobacco)
  • oral state requiring other priority care (untreated cavities, untreated active periodontitis, progressive recession)

研究组 & 干预措施

Experimental group

Experimental

干预措施: Oral probiotics (L. reuteri) (Dietary Supplement)

control group

Sham Comparator

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

Variation of gingival index (Löe Silness) between baseline and 6 months

时间窗: At 6 months

次要结局

  • level of salivary markers of inflammation -(At Baseline, at 3 months and 6 months)
  • plaque index (O'leary)(At Baseline, at 3 months and 6 months)
  • bleeding on probing (BOP) score (% of BOP sites)(At Baseline, at 3 months and 6 months)
  • dysbiosis index(At Baseline, at 3 months and 6 months)
  • compliance level record(At Baseline, at 3 months and 6 months)

研究者

发起方
University Hospital, Lille
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验